价格

Recombinant viral vector

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Recombinant baculovirus vaccine
US 9023365 B2申请人: YOSHIDA SHIGETO优先权: 2006
CN
EP
US
WO
8 件公开
GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS
- EP 3540054 A3
  申请人: GENZYME CORP优先权: 2006
  EP
  US
  WO
  8 件公开
- EP 3632472 A1
  申请人: GENZYME CORP优先权: 2006
  CN
  EP
  US
  7 件公开
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
US 8337857 B2申请人: TANGY FREDERIC优先权: 2005
US
7 件公开
RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION
EP 3268024 B1申请人: UNIV COLUMBIA优先权: 2015
CN
EP
US
WO
6 件公开
RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS VIRAL VECTOR
US 2023226171 A1申请人: LABORATORIO AVI MEX S A DE C V优先权: 2020
CN
EP
US
WO
6 件公开
MODIFIED CPG DINUCLEOTIDES FOR RECOMBINANT VIRAL VECTOR PRODUCTION
EP 4598543 A2申请人: SIREN BIOTECHNOLOGY INC优先权: 2022
CN
EP
US
WO
6 件公开
TREATMENT OF COMPLEMENT-MEDIATED DISORDERS
EP 3454910 B1申请人: CAMBRIDGE ENTPR LTD优先权: 2016
CN
EP
US
WO
5 件公开
VIRAL VECTOR-BASED GENE THERAPY FOR OCULAR CONDITIONS
EP 4294420 A4申请人: UNIV COLORADO REGENTS优先权: 2021
CN
EP
US
WO
5 件公开
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
US 7811812 B2申请人: NOVARTIS VACCINES & DIAGNOSTIC优先权: 2000
US
5 件公开
Recombinant viral vector for gene transfer into lymphoid cells
US 7820436 B2申请人: UNIV OSAKA RES FOUND优先权: 2009
US
5 件公开

药物

Recombinant viral vector

专利

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS